Impact of a surgical approach for implantation of durable left ventricular assist devices in patients on extracorporeal life support.
ECLS
VAD
bleeding
minimally invasive approach
outcome
sternotomy
Journal
Journal of cardiac surgery
ISSN: 1540-8191
Titre abrégé: J Card Surg
Pays: United States
ID NLM: 8908809
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
revised:
28
12
2020
received:
10
12
2020
accepted:
18
01
2021
pubmed:
7
2
2021
medline:
15
5
2021
entrez:
6
2
2021
Statut:
ppublish
Résumé
The aim of this study was to evaluate the impact of the surgical approach on the postoperative outcome in patients who underwent left ventricular assist device (LVAD) implantation after having received veno-arterial extracorporeal life support (va-ECLS) using data from a European registry (ECLS-VAD). Five hundred and thirty-one patients were included. A propensity score-adjusted outcome analysis was performed, resulting in 324 patients in the full sternotomy (FS) group and 39 in the less invasive surgery (LIS) group. The surgery lasted in median 236 min in the FS group versus 263 min in the LIS group (p = 0.289). The median chest tube output during the first 24 h was similar in both groups. Patients who underwent implantation with an FS required more blood products during the first 24 postoperative hours (median 16 vs. 12, p = 0.033). The incidence of revision due to bleeding was also higher (35.5 vs. 15.4%, p = 0.016). A temporary postoperative right ventricular assist device was necessary in 45.1 (FS) versus 23.1% (LIS) of patients, respectively (p = 0.067). No stroke occurred in the LIS group during the first 30 days after surgery (7.4% in the FS group). The incidence of stroke and of renal, hepatic, and respiratory failure during the follow-up was similar in both groups. The 30-day and one-year survival were similar in both groups. LIS for implantation of a durable LVAD in patients on va-ECLS implanted for cardiogenic shock is associated with less revision due to bleeding, less administration of blood products and absence of perioperative stroke, with no impact on survival.
Sections du résumé
BACKGROUND
BACKGROUND
The aim of this study was to evaluate the impact of the surgical approach on the postoperative outcome in patients who underwent left ventricular assist device (LVAD) implantation after having received veno-arterial extracorporeal life support (va-ECLS) using data from a European registry (ECLS-VAD). Five hundred and thirty-one patients were included.
METHODS
METHODS
A propensity score-adjusted outcome analysis was performed, resulting in 324 patients in the full sternotomy (FS) group and 39 in the less invasive surgery (LIS) group.
RESULTS
RESULTS
The surgery lasted in median 236 min in the FS group versus 263 min in the LIS group (p = 0.289). The median chest tube output during the first 24 h was similar in both groups. Patients who underwent implantation with an FS required more blood products during the first 24 postoperative hours (median 16 vs. 12, p = 0.033). The incidence of revision due to bleeding was also higher (35.5 vs. 15.4%, p = 0.016). A temporary postoperative right ventricular assist device was necessary in 45.1 (FS) versus 23.1% (LIS) of patients, respectively (p = 0.067). No stroke occurred in the LIS group during the first 30 days after surgery (7.4% in the FS group). The incidence of stroke and of renal, hepatic, and respiratory failure during the follow-up was similar in both groups. The 30-day and one-year survival were similar in both groups.
CONCLUSION
CONCLUSIONS
LIS for implantation of a durable LVAD in patients on va-ECLS implanted for cardiogenic shock is associated with less revision due to bleeding, less administration of blood products and absence of perioperative stroke, with no impact on survival.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1344-1351Informations de copyright
© 2021 The Authors. Journal of Cardiac Surgery Published by Wiley Periodicals LLC.
Références
Potapov EV, Antonides C, Crespo-Leiro MG, et al. 2019 EACTS expert consensus on long-term mechanical circulatory support. Eur J Cardiothorac Surg. 2019;56:230-270.
Tsyganenko D, Gromann TW, Schoenrath F, et al. Predictors of mid-term outcomes in patients undergoing implantation of a ventricular assist device directly after extracorporeal life support. Eur J Cardiothorac Surg. 2019;55:773-779.
Nersesian G, Hennig F, Müller M, et al. Temporary mechanical circulatory support for refractory heart failure: the German Heart Center Berlin experience. Ann Cardiothorac Surg. 2019;8:76-83.
Loyaga-Rendon RY, Boeve T, Tallaj J, et al. Extracorporeal membrane oxygenation as a bridge to durable mechanical circulatory support: an analysis of the STS-INTERMACS database. Circ Heart Fail. 2020;13:e006387.
Potapov EV, Kukucka M, Falk V, Krabatsch T. Off-pump implantation of the HeartMate 3 left ventricular assist device through a bilateral thoracotomy approach. J Thorac Cardiovasc Surg. 2017;153:104--105.
Saeed D, Sixt S, Albert A, Lichtenberg A. Minimally invasive off-pump implantation of HeartMate 3 left ventricular assist device. J Thorac Cardiovasc Surg. 2016;152:1446-1447.
Gosev I, Wood K, Ayers B, et al. Implantation of a fully magnetically levitated left ventricular assist device using a sternal-sparing surgical technique. J Heart Lung Transplant. 2020;39:37-44.
Saeed D, Potapov E, Loforte A, et al. Transition from temporary to durable circulatory support systems. J Am Coll Cardiol. 2020;76:2956-2964.
Fine JP. JR. G. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496-509.
VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the E-value. Ann Intern Med. 2017;167:268-274.
Potapov EV, Krabatsch T. Minimally invasive continuous-flow left ventricular assist device implantation: avoiding a median sternotomy. J Heart Lung Transplant. 2014;33:1199-1200.
Kormos RL, Cowger J, Pagani FD, et al. The Society of Thoracic Surgeons Intermacs database annual report: evolving indications, outcomes, and scientific partnerships. J Heart Lung Transplant. 2019;38:114-126.
de By TMMH, Mohacsi P, Gahl B, et al. The European Registry for Patients with Mechanical Circulatory Support (EUROMACS) of the European Association for Cardio-Thoracic Surgery (EACTS): second report. Eur J Cardiothorac Surg. 2018;53:309-316.
Kiernan MS, Grandin EW, Brinkley M, et al. Early right ventricular assist device use in patients undergoing continuous-flow left ventricular assist device implantation: incidence and risk factors from the interagency registry for mechanically assisted circulatory support. Circ Heart Fail. 2017;10:10.
Ruel M, Chan V, Boodhwani M, et al. How detrimental is reexploration for bleeding after cardiac surgery? J Thorac Cardiovasc Surg. 2017;154:927-935.
Magruder JT, Belmustakov S, Ohkuma R, et al. Attributable harm of severe bleeding after cardiac surgery in hemodynamically stable patients. Gen Thorac Cardiovasc Surg. 2017;65:102-109.
Frojd V, Jeppsson A. Reexploration for bleeding and its association with mortality after cardiac surgery. Ann Thorac Surg. 2016;102:109-117.